Edition:
United States

SAGE Therapeutics Inc (SAGE.OQ)

SAGE.OQ on NASDAQ Stock Exchange Global Market

162.32USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$162.32
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
281,053
52-wk High
$173.28
52-wk Low
$44.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.967
Jun '17 0.00 -1.879
Mar '17 0.00 -1.523
FY 2016 Dec '16 0.00 -1.498
Sep '16 0.00 -1.146
Jun '16 0.00 -1.084
Mar '16 0.00 -0.965
FY 2015 Dec '15 0.00 -0.991
Sep '15 0.00 -0.836
Jun '15 0.00 -0.898
Mar '15 0.00 -0.658
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 14 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 7 0.00 0.00 0.00 --
Year Ending Dec-17 14 0.00 0.00 0.00 7.82
Year Ending Dec-18 14 12.74 86.30 0.00 53.58
Earnings (per share)
Quarter Ending Dec-17 13 -1.98 -1.79 -2.35 -1.35
Quarter Ending Mar-18 7 -2.00 -1.79 -2.26 --
Year Ending Dec-17 13 -7.38 -7.16 -7.73 -5.05
Year Ending Dec-18 13 -8.21 -6.59 -10.97 -4.19
LT Growth Rate (%) 1 -15.20 -15.20 -15.20 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta 3.09 0.82 0.91
Price to Sales (TTM) -- 122.78 5.95
Price to Book (MRQ) 30.45 23.45 5.68
Price to Tangible Book (MRQ) 33.31 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions -- 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago -- 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -71.65 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago -64.06 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 4.98 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -- -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -- -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -- -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -- -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,314,532 851,801,741
Net Income/Employee (TTM) -1,900,741 -1,997,855 99,542,701
Receivable Turnover (TTM) -- 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.00 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -74.66 -9.39 11.31
Return on Assets - 5 Yr. Avg. -- 0.28 12.28
Return on Investment (TTM) -83.42 -11.76 14.43
Return on Investment - 5 Yr. Avg. -- 3.42 16.07
Return on Equity (TTM) -83.61 -36.72 16.01
Return on Equity - 5 Yr. Avg. -- 5.75 17.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -39.54 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for SAGE Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 267
Total Shares Held: 41,927,052
3 Mo. Net Change: 977,161
# New Positions: 30
# Closed Positions: 41
# Increased Positions: 122
# Reduced Positions: 113
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.